XENE — Xenon Pharmaceuticals Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Xenon Pharmaceuticals Inc (XENE), worth $302.48M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $275.88M | 0.78% | +3.8% |
| Duquesne | $14.40M | 0.33% | NO CHANGE |
| Renaissance | $11.29M | 0.02% | -37.7% |
| IMC | $910.41K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.